DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-0...
DRI Healthcare to Host Third Quarter 2025 Earnings Call and Webcast on November 6, 2025
DRI Healthcare Trust Promotes Zaheed Mawani to Chief Financial Officer
DRI Healthcare to Present at Upcoming Investor Conferences
2025 Second Quarter Earnings Call
DRI Healthcare Reports Second Quarter 2025 Results
DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025
DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetrals...
DRI Healthcare Announces Closing of Internalization Transaction